Powassan virus encephalitis: a literature review

Source:  Powassan virus encephalitis: a literature review    Tag:  encephalitis incubation period

Powassan virus was originally isolated by McLean and Donahue1 from the brain of a 5-year-old boy who developed encephalitis and died in September of 1958. The virus was named Powassan, after the town in northern Ontario where the boy resided. Powassan virus is an arbovirus that has been isolated from 4 species of North America ticks2,3 that belong to the genus Ixodes. Isolates of and antibodies to the Powassan virus have been documented in many rodents and other wild animals,3 as well as in domestic mammals.3-8

Twenty-seven symptomatic cases of Powassan virus encephalitis have been reported in North America between 1958 and 1998; 23 are published9-22 (see Table 1 at www.cma.ca/cmaj for specifics of cases), and 4 are unpublished.23,24 Of note, 11 of the 23 cases were acquired in Canada, 7 of those in Ontario, and the majority (10/12) of cases reported in the United States originated in New York state. Although people may become infected between May and December, they are at greatest risk for Powassan viral infection between June and September.2,3 Males (15/23) and children under the age of 15 (16/23) have been infected most frequently. Although only 7 people reported a tick bite, Ixodes ticks are small and can be easily overlooked on the human body. Two patients had contact with a known host of Powassan virus before the onset of disease,16,25 and 1 patient owned a dog and 2 cats that were infected with ticks and possessed antibodies to Powassan virus.4

The reported incubation periods for Powassan virus range from 8 to 34 days. Smith and colleagues10 reviewed the first 5 known cases of Powassan virus encephalitis and provided the following clinical picture: prodromata including sore throat, sleepiness, headache and disorientation; encephalitis characterized by vomiting, respiratory distress, possible convulsions and prolonged, sustained fever. Lethargy was common throughout the acute phase; patients were occasionally semicomatose, and some degree of paralysis was possible. Five of the diagnosed cases had focal findings, and another patient had major right temporal lobe involvement.16 Hemiplegia was the most common manifestation of neurologic damage; however, recurrent severe headaches,9 minor memory impairment22 and damage to the upper cervical cord, resulting in paralysis and the wasting of right shoulder muscles,12 were also reported. Over half (11/20) of the patients who survived had sequelae, and this rate may actually be higher because follow-up information was not available on some cases.

This case report shows changes similar to those seen in the only other neuropathologically examined case - the first reported case - with an infectious viral meningoencephalitic pattern of changes, chiefly affecting grey matter throughout the brain, and associated with a chronic inflammatory reactive cellular infiltrate of lymphocytes and macrophages. Other similarities include the abundance of perivascular inflammatory cells and multiple foci of parenchymal cells centred in grey matter (Fig. 1, upper panel). In contrast to the initial case, the brain tissue of the patient in this case showed more intense inflammatory infiltrates associated with actual tissue necrosis in the most severely affected areas (i.e., basal ganglia and rostral brain stem). These areas were not associated with a true vasculitis. The lymphocytic reactive population comprised an approximate equal proportion of T and B lymphocytes. In both cases, the meningeal inflammatory component was relatively minor.

Fig. 1: Upper panel, photomicrograph of basal ganglia tissue with characteristic pattern of intense perivascular and infiltrative parenchymal mononuclear cell inflammation, chiefly lymphocytes and macrophages. (Staining with hematoxylin and eosin; original magnification x 200 reduced, by 25%.) Lower panel, brain stem neuron with demarcated cytoplasmic inclusion (arrowhead), consistent with a viral inclusion. (Original magnification x 600, reduced by 22%).

There were focal areas of tissue necrosis associated with the most intense areas of chronic inflammation. This can lead to clinical and radiologic confusion with herpes simplex encephalitis, particularly when temporal lobe involvement is present. The general prominence of grey matter pathology is in keeping with the known neurotropism of arthropod-borne viruses, and with Powassan virus in particular;5,26,27 experimental studies have confirmed a high degree of viral neurotropism.26,27 The accumulation of viral particles has been well demonstrated in neurons and, to a lesser degree, in glial cells. Neuronal accumulation is largely cytoplasmic.27 Mechanisms of neuronal or cellular entry, including any putative membrane viral receptors, are currently unknown. The pathologic changes described here are also similar to those seen with other arboviruses, such as with the equine encephalidities and St. Louis viral encephalitis. Typically, viral inclusions are not found, although previous human neuropathologic examinations are limited to the initial case published in 1959. Ultrastructural examination failed to show viral particles in this case, and this was not unexpected given the marked sampling limitations and postmortem artifactual changes. Careful re-examination of the neuropathologic material showed a rare neuron with an eosinophilic inclusion which most likely represented a viral inclusion (Fig. 1, lower panel). Animal studies have also shown prominent pathologic involvement of spinal cord grey matter,5 but the spinal cord was not available for pathologic examination in this case. However, in keeping with the marked grey matter involvement at higher levels of the neural axis, including the lower brain stem, it is quite reasonable to assume that myelitic inflammatory changes involving the spinal grey matter were present.21 This may have been a contributing factor to the patient's flaccid paralysis.

There is currently no vaccine available for Powassan virus.3,8,28 Education is the best possible defense; people should be aware of tick-borne diseases and learn to avoid any contact with suspected vectors. Human protection is mainly achieved through wearing adequate clothing to minimize exposed skin, treating clothes with insecticides and avoiding or clearing bushy areas. The use of tick repellents and insecticides should be encouraged, and an effort should be made to control ticks in domestic and farm animals and in buildings that they frequent.

It is important for health care providers to consider Powassan virus in the differential diagnosis of aseptic meningitis and encephalitis cases during the summer months. Serum samples should be obtained for serologic testing, and any confirmed cases should be promptly reported to the health authorities.23


  1. McLean DM, Donahue WL. Powassan virus: isolation of virus from a fatal case of encephalitis. CMAJ 1959;80:708-11.
  2. McLean DM, Cobb C, Gooderham SE, Smart CA, Wilson AG, Wilson WE. Powassan virus: persistence of virus activity during 1966. CMAJ 1967;96:660-4.[Medline]
  3. Artsob H. Powassan encephalitis. In: Monath TP, editor. The arboviruses: epidemiology and ecology. vol 4. Boca Raton (FL): CRC Press; 1989. p. 29-49.
  4. Wilson MS, Wherrett BA, Mahdy MS. Powassan virus meningoencephalitis: a case report. CMAJ 1979;121:320-3.[Medline]
  5. Little PB, Thorsen J, Moore W, Weninger N. Powassan virus encephalitis: a review and experimental studies in the horse and rabbit. Vet Pathol 1985;22:500-7.[Abstract]
  6. Whitney E. Arthropod-borne viruses in New York State: serologic evidence of Groups A, B and Bunyamwera viruses in dairy herds. Am J Vet Res 1965;26:914-9.[Medline]
  7. Woodall JP, Roz A. Experimental milk-borne transmission of Powassan virus in the goat. Am J Trop Med Hyg 1977;26:190-2.
  8. Calisher CH. Medically important arboviruses of the United States and Canada. Clin Microbiol Rev 1994;7(1):89-116. [Abstract/ Free Full Text]
  9. Goldfield M, Austin SM, Black HC, Taylor BF, Altman R. A non-fatal human case of Powassan virus encephalitis. Am J Trop Med Hyg 1973;22:78-81.
  10. Smith R, Woodall JP, Whitney E, Deibel R, Gross M, Smith V, et al. Powassan virus infection: a report of three human cases of encephalitis. Am J Dis Child 1974;127:691-3.[Medline]
  11. Rossier E, Harrison RJ, Lemieux B. A case of Powassan virus encephalitis. CMAJ[Medline] 1974;110:1173-80.
  12. Deibel R, Flanagan TD, Smith V. Central nervous system infections in New York State. Etiologic and epidemiologic observations, 1974. N Y State J Med 1975;75:2337-42.[Medline]
  13. Conway D, Rossier E, Spence L, Artsob A. Powassan virus encephalitis with shoulder girdle involvement. Can Dis Wkly Rep 1976;2:85-7.
  14. Deibel R, Flanagan TD, Smith V. Central nervous system infections. Etiologic and epidemiologic observations in New York State, 1975. NY State J Med 1977;77:1398-1404.[Medline]
  15. Rossier E. Powassan encephalitis - Ontario. Can Dis Wkly Rep 1976;2:202-3.
  16. Deibel R, Srihongse S, Woodall JP. Arboviruses in New York State: an attempt to determine the role of arboviruses in patients with viral encephalitis and meningitis. Am J Trop Med Hyg 1979;28:577-82.
  17. Embil JA, Camfield P, Artsob H, Chase DP. Powassan virus encephalitis resembling herpes simplex encephalitis, Arch Intern Med 1983;143:341-3.[Abstract]
  18. Joshua JM, Crapper DR, Spence L, Artsob H, Surgeoner G. A case of Powassan virus encephalitis - Ontario. Can Dis Wkly Rep 1979;5:129-30.
  19. Partington MV, Thomson V, O'Shaughnessy MV. Powassan virus encephalitis in southeastern Ontario. CMAJ 1980;123:603-4.[Medline]
  20. Mahdy MS, Bansen E, McLaughlin B, Artsob H, Spence L, Bact D. California and Powassan virus disease in Ontario 1977-1980. Can Dis Wkly Rep 1982;8:185-91.
  21. Jackson AC. Leg weakness associated with Powassan virus infection - Ontario. Can Dis Wkly Rep 1989;15:123-4.[Medline]
  22. Fitch W, Artsob H. Powassan encephalitis in New Brunswick. Can Fam Physician 1990;33:1289-90.
  23. Arboviral disease - United States, 1994. MMWR 1995;44(35):641-4.[Medline]
  24. Kolski H, Ford-Jones EL, Richardson S, Petric M, Nelson S, Jamieson F, et al. Etiology of acute childhood encephalitis at Hospital for Sick Children, Toronto, 1994-1995. Clin Infect Dis 1998;26:398-409.[Medline]
  25. McLean DM, MacPherson LW, Walker SJ, Funk G. Powassan virus: surveys of human and animal sera. Am J Public Health 1960;50:1539.
  26. Frolova MP, Isachkova LM, Shestopalova NM, Pogodina VV. Experimental encephalitis monkeys caused by Powassan virus. Neurosci Behav Physiol 1985;15(1):62-9.[Medline]
  27. Isachkova LM, Shestopalova NM, Frolova MP, Reingold VN. Light and electron microscope of the neurotropism of Powassan virus strain P-40. Acta Virol 1979;23(1):40-4.[Medline]
  28. Costero A, Grayson M. Experimental transmission of Powassan virus (flaviviridae) by Ixodes scapularis ticks (acari:ixodidae). Am J Trop Med Hyg 1996;55(5):536-46.